Literature DB >> 23684417

Pathogenesis of Lassa fever virus infection: I. Susceptibility of mice to recombinant Lassa Gp/LCMV chimeric virus.

Andrew M Lee1, Justin Cruite, Megan J Welch, Brian Sullivan, Michael B A Oldstone.   

Abstract

Lassa virus (LASV) is a BSL-4 restricted agent. To allow study of infection by LASV under BSL-2 conditions, we generated a recombinant virus in which the LASV glycoprotein (Gp) was placed on the backbone of lymphocytic choriomeningitis virus (LCMV) Cl13 nucleoprotein, Z and polymerase genes (rLCMV Cl13/LASV Gp). The recombinant virus displayed high tropism for dendritic cells following in vitro or in vivo infection. Inoculation of immunocompetent adults resulted in an acute infection, generation of virus-specific CD8(+) T cells and clearance of the infection. Inoculation of newborn mice with rLCMV Cl13/LASV Gp resulted in a life-long persistent infection. Interestingly, adoptive transfer of rLCMV Cl13/LASV Gp immune memory cells into such persistently infected mice failed to purge virus but, in contrast, cleared virus from mice persistently infected with wt LCMV Cl13.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23684417      PMCID: PMC3686847          DOI: 10.1016/j.virol.2013.04.010

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  39 in total

1.  Point mutation in the glycoprotein of lymphocytic choriomeningitis virus is necessary for receptor binding, dendritic cell infection, and long-term persistence.

Authors:  Brian M Sullivan; Sébastien F Emonet; Megan J Welch; Andrew M Lee; Kevin P Campbell; Juan C de la Torre; Michael B Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-26       Impact factor: 11.205

2.  Defining parameters for successful immunocytotherapy of persistent viral infection.

Authors:  D P Berger; D Homann; M B Oldstone
Journal:  Virology       Date:  2000-01-20       Impact factor: 3.616

3.  Role of interferons in the control of Lassa virus replication in human dendritic cells and macrophages.

Authors:  Sylvain Baize; Delphine Pannetier; Caroline Faure; Philippe Marianneau; Ingrid Marendat; Marie-Claude Georges-Courbot; Vincent Deubel
Journal:  Microbes Infect       Date:  2006-03-20       Impact factor: 2.700

4.  Interleukin-10 determines viral clearance or persistence in vivo.

Authors:  David G Brooks; Matthew J Trifilo; Kurt H Edelmann; Luc Teyton; Dorian B McGavern; Michael B A Oldstone
Journal:  Nat Med       Date:  2006-10-15       Impact factor: 53.440

5.  Toll-like receptor 7 is required for effective adaptive immune responses that prevent persistent virus infection.

Authors:  Kevin B Walsh; John R Teijaro; Elina I Zuniga; Megan J Welch; Daniel M Fremgen; Shawn D Blackburn; Karl F von Tiehl; E John Wherry; Richard A Flavell; Michael B A Oldstone
Journal:  Cell Host Microbe       Date:  2012-06-14       Impact factor: 21.023

6.  Differences in affinity of binding of lymphocytic choriomeningitis virus strains to the cellular receptor alpha-dystroglycan correlate with viral tropism and disease kinetics.

Authors:  S C Smelt; P Borrow; S Kunz; W Cao; A Tishon; H Lewicki; K P Campbell; M B Oldstone
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

7.  T cell-dependence of Lassa fever pathogenesis.

Authors:  Lukas Flatz; Toni Rieger; Doron Merkler; Andreas Bergthaler; Tommy Regen; Mariann Schedensack; Lukas Bestmann; Admar Verschoor; Mario Kreutzfeldt; Wolfgang Brück; Uwe-Karsten Hanisch; Stephan Günther; Daniel D Pinschewer
Journal:  PLoS Pathog       Date:  2010-03-26       Impact factor: 6.823

8.  Different mechanisms of cell entry by human-pathogenic Old World and New World arenaviruses.

Authors:  Jillian M Rojek; Ana B Sanchez; Ngoc Thao Nguyen; Juan-Carlos de la Torre; Stefan Kunz
Journal:  J Virol       Date:  2008-05-28       Impact factor: 5.103

9.  Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells.

Authors:  N Sevilla; S Kunz; A Holz; H Lewicki; D Homann; H Yamada; K P Campbell; J C de La Torre; M B Oldstone
Journal:  J Exp Med       Date:  2000-11-06       Impact factor: 14.307

10.  Molecular analysis of the interaction of LCMV with its cellular receptor [alpha]-dystroglycan.

Authors:  S Kunz; N Sevilla; D B McGavern; K P Campbell; M B Oldstone
Journal:  J Cell Biol       Date:  2001-10-15       Impact factor: 10.539

View more
  16 in total

1.  The Anatomy of a Career in Science.

Authors:  Michael B A Oldstone
Journal:  DNA Cell Biol       Date:  2016-02-02       Impact factor: 3.311

2.  Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.

Authors:  Sylvia Rothenberger; Christian Widmann; Stefan Kunz; Giulia Torriani; Evgeniya Trofimenko; Jennifer Mayor; Chiara Fedeli; Hector Moreno; Sébastien Michel; Mathieu Heulot; Nadja Chevalier; Gert Zimmer; Neeta Shrestha; Philippe Plattet; Olivier Engler
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

3.  Blockade of interferon Beta, but not interferon alpha, signaling controls persistent viral infection.

Authors:  Cherie T Ng; Brian M Sullivan; John R Teijaro; Andrew M Lee; Megan Welch; Stephanie Rice; Kathleen C F Sheehan; Robert D Schreiber; Michael B A Oldstone
Journal:  Cell Host Microbe       Date:  2015-05-13       Impact factor: 21.023

4.  Type I interferon is a therapeutic target for virus-induced lethal vascular damage.

Authors:  Roberto Baccala; Megan J Welch; Rosana Gonzalez-Quintial; Kevin B Walsh; John R Teijaro; Anthony Nguyen; Cherie T Ng; Brian M Sullivan; Alessandro Zarpellon; Zaverio M Ruggeri; Juan Carlos de la Torre; Argyrios N Theofilopoulos; Michael B A Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-02       Impact factor: 11.205

5.  Lymphocytic choriomeningitis virus Clone 13 infection causes either persistence or acute death dependent on IFN-1, cytotoxic T lymphocytes (CTLs), and host genetics.

Authors:  Michael B A Oldstone; Brian C Ware; Lucy E Horton; Megan J Welch; Roberto Aiolfi; Alessandro Zarpellon; Zaverio M Ruggeri; Brian M Sullivan
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-30       Impact factor: 11.205

6.  Residues K465 and G467 within the Cytoplasmic Domain of GP2 Play a Critical Role in the Persistence of Lymphocytic Choriomeningitis Virus in Mice.

Authors:  Masaharu Iwasaki; Cherie T Ng; Beatrice Cubitt; Juan C de la Torre
Journal:  J Virol       Date:  2016-10-28       Impact factor: 5.103

7.  Axl Can Serve as Entry Factor for Lassa Virus Depending on the Functional Glycosylation of Dystroglycan.

Authors:  Chiara Fedeli; Giulia Torriani; Clara Galan-Navarro; Marie-Laurence Moraz; Hector Moreno; Gisa Gerold; Stefan Kunz
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

8.  A Jekyll and Hyde Profile: Type 1 Interferon Signaling Plays a Prominent Role in the Initiation and Maintenance of a Persistent Virus Infection.

Authors:  Michael B A Oldstone
Journal:  J Infect Dis       Date:  2015-07-15       Impact factor: 5.226

9.  Role of DC-SIGN in Lassa virus entry into human dendritic cells.

Authors:  Ana-Rita Goncalves; Marie-Laurence Moraz; Antonella Pasquato; Ari Helenius; Pierre-Yves Lozach; Stefan Kunz
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

10.  Lassa Virus Cell Entry via Dystroglycan Involves an Unusual Pathway of Macropinocytosis.

Authors:  Joel Oppliger; Giulia Torriani; Antonio Herrador; Stefan Kunz
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.